Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis could cut its Kymriah price to $160,000 and keep its profit margins: study
Novartis could cut its Kymriah price to $160,000 and keep its profit margins: study
Novartis could cut its Kymriah price to $160,000 and keep its profit margins: study
Submitted by
admin
on February 8, 2018 - 11:55pm
Source:
Fierce Pharma
News Tags:
Novartis
Kymriah
pricing
Headline:
Novartis could cut its Kymriah price to $160,000 and keep its profit margins: study
Do Not Allow Advertisers to Use My Personal information
